247 Health News is committed to the highest standards of evidence-based editorial practice. This page describes our editorial commitment, the frameworks we apply, our source selection criteria, and our policies on independence, quality assurance, corrections, and the use of artificial intelligence tools.
1. Our Editorial Commitment
All research appraisals published on 247 Health News are conducted using the Centre for Evidence-Based Medicine (CEBM) Oxford critical appraisal framework. This ensures that every piece of research we evaluate is assessed through a consistent, transparent, and methodologically sound lens.
Our editorial team consists of specialists in evidence-based medicine, clinical research methodology, and health technology — professionals who bring both academic rigour and clinical understanding to every appraisal and article we publish.
2. CEBM Appraisal Framework
The Oxford Centre for Evidence-Based Medicine (CEBM) Levels of Evidence provide a hierarchy for evaluating the strength and quality of clinical evidence. Each level reflects the degree to which a study design can reduce bias and support valid conclusions:
Systematic reviews of randomised controlled trials (RCTs) — the highest quality evidence.
Individual RCTs or observational studies with dramatic effects.
Non-randomised controlled cohort or follow-up studies.
Case series, case-control studies, or historically controlled studies.
Mechanism-based reasoning or expert opinion.
We apply the CEBM critical appraisal tools to assess study quality within each level — examining factors such as randomisation quality, blinding, allocation concealment, sample size, follow-up completeness, and statistical validity.
For full details of the CEBM Levels of Evidence, visit the Oxford CEBM at cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence.
3. Source Selection
We apply strict source selection criteria to ensure all content is grounded in credible, verifiable evidence.
Clinical Research
We source clinical trials exclusively from WHO-registered trial registries, including:
- ClinicalTrials.gov (United States National Library of Medicine)
- ANZCTR (Australian New Zealand Clinical Trials Registry)
- ISRCTN (International Standard Randomised Controlled Trial Number registry)
- WHO-ICTRP (WHO International Clinical Trials Registry Platform)
News & Technology Content
News and health technology content is sourced exclusively from peer-reviewed journals, regulatory bodies (such as the TGA, FDA, EMA, and MHRA), and established professional organisations. We do not republish content from unverified, predatory, or non-peer-reviewed sources.
4. Editorial Independence
Editorial content is never influenced by advertisers, sponsors, or affiliate relationships.
All editorial decisions — including which research to appraise, which topics to cover, and how content is framed — are made solely by our editorial team based on clinical relevance, evidence quality, and reader value.
Sponsored content is always clearly labelled as "Sponsored" and visually separated from editorial content. No sponsor or advertiser has any ability to influence, review, or modify editorial copy prior to publication.
5. Quality Assurance
All content published on 247 Health News passes through a multi-layer quality assurance process before publication:
Automated CEBM Scoring
Each clinical study is processed through our automated scoring pipeline, which assesses study type, registry status, and initial quality indicators against the CEBM framework.
Content Moderation
Our content moderation layer screens for factual consistency, source verification, and compliance with our source selection criteria before content proceeds to editorial review.
Human Editorial Review
Flagged items — including those with complex methodology, high clinical impact, or ambiguous evidence — are reviewed by a human editor with relevant clinical or research expertise before publication.
6. Corrections Policy
We are committed to accuracy. Errors can occur, and we take our responsibility to correct them seriously.
If you identify an error — factual, methodological, or interpretive — in any published content, please contact us at [email protected] with the article title, the specific error, and your suggested correction.
Verified corrections are made promptly. A correction notice is appended to the affected article noting the nature of the error and the date it was corrected. We do not silently edit published content.
7. Transparency on AI Tools
247 Health News uses artificial intelligence tools to assist with literature monitoring, initial screening of clinical trials, and content structuring. These tools help us efficiently process the large volume of research published daily across global health literature.
All published content undergoes our full quality assurance process, including human editorial review where required. AI-generated drafts or summaries are never published without editorial oversight and validation.
Our editorial standards, not our tools, determine what is published.
8. Contact
For questions about our editorial standards, corrections, or content policies, please contact the editorial team at [email protected].
We welcome feedback from healthcare professionals, researchers, and readers. Your expertise helps us maintain the accuracy and relevance of our content.
247 Health News is operated by Vyrelium Holdings (ACN 695 087 177). All appraisals use the Oxford CEBM framework. Editorial decisions are made independently of commercial relationships. Questions? Email [email protected].